Hong Kong-listed biopharmaceutical stocks rose during the session, with InnoCare Pharma (02359.HK) and WuXi AppTec (02359.HK) both rising by more than 4%, Tiger Pharmaceuticals (03347.HK) rising by more than 3.5%, GenScript Biotech (01548.HK), Zai Lab (09688.HK), WuXi Biologics (02269.HK), and BeiGene (06160.HK) all rising by more than 2%.

2024-12-30 10:01:30

BeiGene WuXi Biologics WuXi AppTec

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Southwest Airlines CEO: Although Boeing still has a lot of work to do, they seem to be moving in a good direction and we are more optimistic.
                            2025-01-31

                                    White House Press Secretary Levitt: Details about the Nvidia meeting are still unclear.
                            2025-02-01

                                    Apple (AAPL.O) said the Apple Pay outage has been resolved.
                            2025-01-29

                                    Jefferies: Raised Meta Platforms (META.O) price target from $715 to $810.
                            2025-01-30

                                    Sam Altman, founder and CEO of OpenAI: OpenAI will develop specialized hardware for AI.
                            2025-02-03